Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences Profit Margin 2006-2019 | GILD

Current and historical gross margin, operating margin and net profit margin for Gilead Sciences (GILD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Gilead Sciences net profit margin as of September 30, 2019 is 12.04%.
  
Gilead Sciences Annual Profit Margins
Gilead Sciences Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $82.234B $22.127B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $133.394B 15.37
CSL (CSLLY) Australia $84.649B 0.00
Celgene (CELG) United States $76.958B 10.99
Vertex Pharmaceuticals (VRTX) United States $55.287B 56.43
Biogen (BIIB) United States $51.504B 8.84
Illumina (ILMN) United States $45.718B 50.16
Regeneron Pharmaceuticals (REGN) United States $37.820B 16.56
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.486B 12.09
Seattle Genetics (SGEN) United States $20.203B 0.00
Incyte (INCY) United States $18.942B 43.97
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.938B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.962B 0.00
Genmab (GNMSF) Denmark $13.799B 60.95
Alnylam Pharmaceuticals (ALNY) United States $10.918B 0.00
Exact Sciences (EXAS) United States $10.880B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Galapagos (GLPG) Belgium $10.106B 26.04
BeiGene (BGNE) Cayman Islands $9.682B 0.00
QIAGEN (QGEN) Netherlands $9.255B 30.18
Bio-Techne Corp (TECH) United States $8.245B 55.19
Amarin (AMRN) Ireland $8.119B 0.00
Guardant Health (GH) United States $7.358B 0.00
Sarepta Therapeutics (SRPT) United States $7.308B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.210B 0.00
Moderna (MRNA) United States $6.452B 0.00
Reata Pharmaceuticals (RETA) United States $6.202B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.713B 14.52
Medicines (MDCO) United States $5.597B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.588B 0.00
Exelixis (EXEL) United States $5.023B 14.13
Ascendis Pharma (ASND) Denmark $4.781B 0.00
China Biologic Products (CBPO) China $4.593B 25.87
Repligen (RGEN) United States $4.511B 81.75
Spark Therapeutics (ONCE) United States $4.289B 0.00
Bluebird Bio (BLUE) United States $4.094B 0.00
Blueprint Medicines (BPMC) United States $3.795B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.779B 0.00
Mirati Therapeutics (MRTX) United States $3.776B 0.00
MorphoSys AG (MOR) Germany $3.661B 0.00
Immunomedics (IMMU) United States $3.623B 0.00
Adaptive Biotechnologies (ADPT) United States $3.587B 0.00
Alkermes (ALKS) Ireland $3.143B 0.00
Genmab (GMAB) Denmark $2.907B 5.99
Halozyme Therapeutics (HALO) United States $2.806B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.800B 0.00
Emergent Biosolutions (EBS) United States $2.793B 27.75
MyoKardia (MYOK) United States $2.597B 0.00
NeoGenomics (NEO) United States $2.529B 134.56
Amicus Therapeutics (FOLD) United States $2.487B 0.00
UniQure (QURE) Netherlands $2.399B 0.00
Arena Pharmaceuticals (ARNA) United States $2.311B 5.38
Acceleron Pharma (XLRN) United States $2.293B 0.00
Zai Lab (ZLAB) China $2.243B 0.00
RA PHARMCTL INC (RARX) United States $2.198B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.166B 0.00
Cambrex (CBM) United States $2.018B 25.46
Myriad Genetics (MYGN) United States $1.869B 27.61
Insmed (INSM) United States $1.846B 0.00
Ligand Pharmaceuticals (LGND) United States $1.823B 35.06
Akcea Therapeutics (AKCA) United States $1.792B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.642B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.539B 0.00
Denali Therapeutics (DNLI) United States $1.534B 0.00
Zymeworks (ZYME) Canada $1.508B 0.00
Epizyme (EPZM) United States $1.461B 0.00
REGENXBIO (RGNX) United States $1.406B 0.00
Coherus BioSciences (CHRS) United States $1.375B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.328B 0.00
Editas Medicine (EDIT) United States $1.281B 0.00
Innoviva (INVA) United States $1.265B 3.73
Athenex (ATNX) United States $1.203B 0.00
Zealand Pharma (ZLDPF) Denmark $1.185B 0.00
Sangamo Therapeutics (SGMO) United States $1.122B 0.00
Arvinas (ARVN) United States $1.105B 0.00
WAVE Life Sciences (WVE) Singapore $1.101B 0.00
Fate Therapeutics (FATE) United States $1.096B 0.00
Alector (ALEC) United States $1.067B 0.00
Zealand Pharma (ZEAL) Denmark $1.038B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.011B 0.00
Principia Biopharma (PRNB) United States $0.983B 0.00
Cara Therapeutics (CARA) United States $0.897B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.879B 0.00
Codexis (CDXS) United States $0.875B 0.00
Anika Therapeutics (ANIK) United States $0.858B 27.84
ZIOPHARM Oncology Inc (ZIOP) United States $0.840B 0.00
Vericel (VCEL) United States $0.828B 308.83
Vanda Pharmaceuticals (VNDA) United States $0.826B 6.95
BAVARIAN NORDIC (BVNRY) Denmark $0.791B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 0.00
Intellia Therapeutics (NTLA) United States $0.732B 0.00
Revance Therapeutics (RVNC) United States $0.731B 0.00
Heska (HSKA) United States $0.718B 183.44
Twist Bioscience (TWST) United States $0.713B 0.00
ANI Pharmaceuticals (ANIP) United States $0.684B 11.66
DBV Technologies S.A (DBVT) France $0.674B 0.00
MiMedx (MDXG) United States $0.659B 0.00
Precision BioSciences (DTIL) United States $0.637B 0.00
Adverum Biotechnologies (ADVM) United States $0.621B 0.00
Mesoblast (MESO) Australia $0.604B 0.00
Agenus (AGEN) United States $0.599B 0.00
UROGEN PHARMA (URGN) United States $0.589B 0.00
GENFIT S.A (GNFT) France $0.585B 0.00
Cellectis S.A (CLLS) France $0.561B 0.00
Retrophin (RTRX) United States $0.556B 0.00
BioDelivery Sciences (BDSI) United States $0.551B 0.00
Cytokineticsorporated (CYTK) United States $0.547B 0.00
Kadmon Holdings (KDMN) United States $0.538B 0.00
Stemline Therapeutics (STML) United States $0.533B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.509B 0.00
AC Immune SA (ACIU) Switzerland $0.504B 11.66
Intra-Cellular Therapies (ITCI) United States $0.497B 0.00
Dynavax Technologies (DVAX) United States $0.495B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.493B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
PHARMA MAR SA (PHMMF) Spain $0.440B 0.00
Prothena (PRTA) Ireland $0.431B 0.00
Clovis Oncology (CLVS) United States $0.427B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.388B 2.68
Bellus Health (BLU) Canada $0.386B 0.00
Merus (MRUS) Netherlands $0.365B 0.00
PDL BioPharma (PDLI) United States $0.352B 8.80
Cellular Biomedicine (CBMG) United States $0.347B 0.00
Arcus Biosciences (RCUS) United States $0.347B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.328B 0.00
Puma Biotechnology (PBYI) United States $0.327B 0.00
Starpharma Holdings (SPHRY) Australia $0.322B 0.00
AnaptysBio (ANAB) United States $0.300B 0.00
Compugen (CGEN) Israel $0.298B 0.00
Avid Bioservices (CDMO) United States $0.294B 0.00
Kindred Biosciences (KIN) United States $0.293B 0.00
Protagonist Therapeutics (PTGX) United States $0.289B 0.00
Pfenex (PFNX) United States $0.285B 0.00
Gritstone Oncology (GRTS) United States $0.284B 0.00
Cel-Sci (CVM) United States $0.271B 0.00
Seres Therapeutics (MCRB) United States $0.262B 0.00
Theratechnologies (THTX) Canada $0.262B 0.00
Geron (GERN) United States $0.261B 0.00
Sutro Biopharma (STRO) United States $0.259B 0.00
OSMOTICA PHARM (OSMT) United States $0.258B 0.00
ADMA Biologics Inc (ADMA) United States $0.255B 0.00
Scholar Rock Holding (SRRK) United States $0.245B 0.00
MannKind (MNKD) United States $0.244B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.241B 0.00
Kamada (KMDA) Israel $0.240B 7.00
Inovio Pharmaceuticals (INO) United States $0.237B 0.00
Albireo Pharma (ALBO) United States $0.236B 0.00
CytomX Therapeutics (CTMX) United States $0.235B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.232B 0.00
XOMA (XOMA) United States $0.228B 0.00
Athersys (ATHX) United States $0.222B 0.00
Cue Biopharma (CUE) United States $0.220B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.208B 0.00
Syros Pharmaceuticals (SYRS) United States $0.208B 0.00
ChromaDex (CDXC) United States $0.207B 0.00
Sorrento Therapeutics (SRNE) United States $0.203B 0.00
Biofrontera AG (BFRA) Germany $0.201B 0.00
Exicure (XCUR) United States $0.198B 0.00
Spero Therapeutics (SPRO) United States $0.191B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.188B 0.00
Arsanis (XFOR) United States $0.179B 0.00
Affimed (AFMD) Germany $0.178B 0.00
Palatin Technologies (PTN) United States $0.178B 4.85
CorMedix Inc (CRMD) United States $0.172B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.171B 0.00
Senesco Technologies (ELOX) United States $0.171B 0.00
Dyadic (DYAI) United States $0.171B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.150B 0.00
Cerecor (CERC) United States $0.148B 0.00
Alcobra (ARCT) United States $0.145B 0.00
Nicox SA (NICXF) France $0.141B 0.00
Enzo Biochem (ENZ) United States $0.135B 0.00
Fortress Biotech (FBIO) United States $0.132B 0.00
BioTime (LCTX) United States $0.128B 6.57
Northwest Biotherapeutics (NWBO) United States $0.128B 0.00
Mersana Therapeutics (MRSN) United States $0.125B 0.00
Ophthotech (ISEE) United States $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.119B 0.00
Abeona Therapeutics (ABEO) United States $0.119B 0.00
Emmaus Life Sciences (EMMA) United States $0.118B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.118B 0.00
Five Prime Therapeutics (FPRX) United States $0.118B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.117B 0.00
NantKwest (NK) United States $0.113B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
OvaScience (MLND) United States $0.110B 0.00
Celyad SA (CYAD) Belgium $0.109B 0.00
Aptinyx (APTX) United States $0.107B 0.00
VBI Vaccines (VBIV) United States $0.105B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.102B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.101B 0.00
Novavax (NVAX) United States $0.100B 0.00
Menlo Therapeutics (MNLO) United States $0.099B 0.00
PHASEBIO PHARMA (PHAS) United States $0.096B 0.00
Aduro Biotech (ADRO) United States $0.089B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.085B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.084B 0.00
Strongbridge Biopharma (SBBP) United States $0.081B 2.17
Acorda Therapeutics (ACOR) United States $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.076B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.072B 0.00
Selecta Biosciences (SELB) United States $0.068B 0.00
Vaccinex (VCNX) United States $0.068B 0.00
Synlogic (SYBX) United States $0.068B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Verastem (VSTM) United States $0.066B 0.00
Liquidia Technologies (LQDA) United States $0.064B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Trevena (TRVN) United States $0.063B 0.00
Catalyst Biosciences (CBIO) United States $0.062B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Idera Pharmaceuticals (IDRA) United States $0.059B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.059B 0.00
Checkpoint Therapeutics (CKPT) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.056B 0.00
Orgenesis (ORGS) United States $0.054B 3.50
Merrimack Pharmaceuticals (MACK) United States $0.053B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.053B 0.00
Applied Genetic Technologies (AGTC) United States $0.053B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Pluristem Therapeutics (PSTI) Israel $0.050B 0.00
AIT Therapeutics (XAIR) United States $0.048B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.046B 0.00
Curis (CRIS) United States $0.046B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
AquaBounty Technologies (AQB) United States $0.045B 0.00
DiaMedica Therapeutics (DMAC) United States $0.044B 0.00
Clearside Biomedical (CLSD) United States $0.043B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.041B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.034B 0.00
Celsion (CLSN) United States $0.033B 0.00
Oncobiologics (OTLK) United States $0.031B 0.00
VIVUS (VVUS) United States $0.030B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.56
Caladrius Biosciences (CLBS) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
BioCardia (BCDA) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Apricus Biosciences (SEEL) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.021B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Soligenix (SNGX) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
VistaGen Therapeutics (VTGN) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Cleveland BioLabs (CBLI) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.003B 0.00
Neuralstem (SNCA) United States $0.002B 0.00